TROBALT 50mg tablets medication leaflet

N03AX21 retigabine • Nervous system | Antiepileptics | Other antiepileptics

Retigabine is a medication used as an adjunctive treatment for partial epileptic seizures in adult patients. It works by activating potassium channels in the brain, reducing neuronal excitability and thereby preventing seizures.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important not to abruptly stop the treatment, as this may worsen seizures.

Side effects may include drowsiness, dizziness, blurred vision, or difficulty concentrating. In rare cases, severe adverse effects such as changes in skin or eye color may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney or liver diseases, to ensure the safe use of retigabine.

General data about TROBALT 50mg

Substance: retigabine

Date of last drug list: 01-08-2018

Commercial code: W57376002

Concentration: 50mg

Pharmaceutical form: tablets

Quantity: 84

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for retigabine

100mg, 200mg, 300mg, 400mg, 50mg, 50mg/100mg